LAKE FOREST, Calif., Oct. 5 /PRNewswire/ -- A versatile, new, multi-treatment LED (Light Emitting Diode) device from the pioneer of photodynamic therapy is changing how dermatology and plastic surgery patients are treated. Today's consumer wants more effective, less aggressive skin treatments for acne, rosacea, psoriasis, and a variety of other skin disorders as well as to repair aging and sun-damaged skin, and the highly versatile Omnilux is the answer. With three easily inter-changeable treatment heads, each with a selective wave length and light intensity, Omnilux' pure, narrow-band light activates a series of cellular responses in the mitochondria, the powerhouse of the cells, to naturally correct a wide array of skin disorders. Omnilux light therapy selectively stimulates various cellular functions: Revive stimulates the fibroblasts to produce more collagen and elastin giving skin more firmness and an improved texture; Omnilux Blue and Plus help regulate other skin functions, such as sebum (oil) production, inflammation and wound healing.
More than 2,200 physicians worldwide are now using Omnilux Light Therapy in their practice, and their grateful patients are spreading the word. A safe modality for all skin colors, Omnilux not only repairs signs of aging, but also reduces post-surgery healing time by accelerating wound healing after more invasive procedures. Light therapy actually reduces erythema (redness), pain and swelling after chemical peels, dermabrasion, IPL and laser surgery and even after plastic surgeries such as blepharoplasty (eyelid surgery) and mammoplasty (breast surgery). Omnilux is completely pain-free, and generally requires a series of 6 to 8 treatments performed on clean skin over a 4 to 8 week period.
The Omnilux light trio is an FDA-approved medical device, whose scientific heritage spans nearly 20 years. It is FDA approved for both safety and efficacy, and is supported by more than forty-five independent peer review studies, plus Omnilux treatments are compatible with other existing skin rejuvenation procedures such as Botox(TM), dermal fillers and thread lifts.
Protected by more than 35 worldwide patent applications by the parent company, Photo Therapeutics, in Staffordshire, England, is considered the world leader in the science and research of Light Therapy. Omnilux Light Therapy treatments are available only through physicians and leading medical esthetic spas across the country.
To learn more, visit their website at phototherapeutics.com to find where treatments are available in your area. For interviews and access to leading medical doctors or medical spas offering Omnilux treatments, call Esche & Alexander Public Relations at 760-414-3370 or email sharon@beauty-pr.com.
List of FDA Approvals for Omnilux Light Therapy
June 20, 2003 - Omnilux Blue (415 nm) - approved for general dermatological conditions and specifically to treat moderate, inflammatory acne vulgaris.
July 17, 2003 - Omnilux Revive (633 nm) - approved for use in dermatology for treatment of superficial, benign, vascular, and pigmented lesions.
March 15, 2005 - Omnilux Plus (830 nm) - approved for the relief of minor muscle and joint pain.
March 18, 2005 - Omnilux Revive (633 nm) & Omnilux Blue (415 nm) - approved for the treatment of mild to moderate acne vulgaris.
August 9, 2005 - Omnilux Revive (633 nm) & Omnilux Plus (830 nm) - approved for use in dermatology for the treatment of periorbital wrinkles.
Contact: Esche & Alexander Public Relations Sharon Esche 760-414-3370 866-317-2963-fax sharon@beauty-pr.comwww.beauty-pr.com
Photo TherapeuticsCONTACT: Sharon Esche of Esche & Alexander Public Relations,+1-760-414-3370, or fax, +1-866-317-2963, sharon@beauty-pr.com, for PhotoTherapeutics
Web site: http://www.phototherapeutics.com/
